Mepenzolate Bromide (CAS 76-90-4)
QUICK LINKS
Mepenzolate bromide is a quaternary ammonium compound that functions as a muscarinic receptor antagonist. It exerts its mechanism of action by competitively inhibiting the binding of acetylcholine to muscarinic receptors in smooth muscle, thereby blocking the downstream signaling cascade. This results in the relaxation of smooth muscle in the gastrointestinal tract and other organs, leading to decreased gastrointestinal motility and secretions. At the molecular level, mepenzolate bromide targets and blocks the M1 and M3 subtypes of muscarinic receptors, which are predominantly expressed in smooth muscle and exocrine glands. By interfering with the cholinergic signaling pathway, mepenzolate bromide effectively modulates smooth muscle tone and secretory activity, making it useful in investigating the physiological and pathophysiological roles of muscarinic receptors in various experiment.
Mepenzolate Bromide (CAS 76-90-4) References
- Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease. | Tanaka, K., et al. 2014. Sci Rep. 4: 4510. PMID: 24676126
- Ameliorative effect of mepenzolate bromide against pulmonary fibrosis. | Kurotsu, S., et al. 2014. J Pharmacol Exp Ther. 350: 79-88. PMID: 24769542
- Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities. | Yamashita, Y., et al. 2014. Bioorg Med Chem. 22: 3488-97. PMID: 24844758
- Mepenzolate bromide promotes diabetic wound healing by modulating inflammation and oxidative stress. | Zheng, Y., et al. 2016. Am J Transl Res. 8: 2738-47. PMID: 27398156
- Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2. | Miao, W., et al. 2016. Int J Mol Sci. 17: PMID: 27735862
- Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis. | Salem, HA. and Wadie, W. 2017. Sci Rep. 7: 7139. PMID: 28769047
- Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity. | Tanaka, KI., et al. 2018. Front Pharmacol. 9: 344. PMID: 29692733
- Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. | Yamashita, Y., et al. 2019. Bioorg Med Chem. 27: 3339-3346. PMID: 31204225
- Visible-light photoredox-catalyzed umpolung carboxylation of carbonyl compounds with CO2. | Cao, GM., et al. 2021. Nat Commun. 12: 3306. PMID: 34083530
- Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups. | Okazaki, Y., et al. 2022. BMC Gastroenterol. 22: 263. PMID: 35619078
- Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor. | Ibrahim, WW., et al. 2022. Prog Neuropsychopharmacol Biol Psychiatry. 119: 110583. PMID: 35690118
- A compilation of LD50 values in newborn and adult animals. | Goldenthal, EI. 1971. Toxicol Appl Pharmacol. 18: 185-207. PMID: 5542824
- [Effect of tiemonium iodide on colonic motility in dogs]. | Okada, K., et al. 1982. Nihon Yakurigaku Zasshi. 80: 495-503. PMID: 6962171
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mepenzolate Bromide, 5 g | sc-358272 | 5 g | $87.00 |